Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a daily pill give you better skin? new study tests two supplements against placebo

NCT ID NCT07640321

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study compared two oral dietary supplements—N-acetylneuraminic acid and ACAI-PLUS—against a placebo in 83 women aged 40 to 65. Over 84 days, researchers measured changes in skin elasticity, wrinkles, moisture, and tone using both doctor assessments and participant self-reports. The goal was to see if these supplements could improve facial skin appearance under normal daily use.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
N-acetylneuraminic acid and ACAI-PLUS (oral dietary supplements)
What this could lead to
If successful, these supplements could offer a non-invasive option to improve skin firmness, reduce wrinkles, and enhance hydration.
What could go wrong
This is a small, early-stage trial with only 83 participants, so results may not apply to everyone. As a cosmetic supplement, any benefits are likely modest and not a medical treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

83 people

The number who actually took part.

Started

Sep 2023

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Chinese Asian women aged 40-65, with facial skin issues such as pigmentation spots, lack of elasticity, and wrinkles

Ages

40 to 65 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Skin type origin: Asian in China * Age: from 40 to 65 years old * Gender: female * Specific criteria: • All skin type on the face Dry, dry combination, normal 1. presenting with a lack of elasticity to the face, inclusion grade ≤ 6 according 10 points scale 2. presenting with a lack of density to the face, inclusion grade ≤ 6 according 10 points scale 3. presenting with wrinkles on crow's feet area, grade ≥ 2 according to Skin ageing atlas Vol.2 (p.41) 4. presenting with pigmentary spots with at least one with diameter ≥ 3mm * Usual or occasional user of food supplements * Able to give her informed consent Exclusion Criteria: The non-inclusion general criteria were the following ones: * allergies or reactivity to cosmetic products, * for the subjects undergoing hormonal treatment; change of treatment within 3 months preceding the inclusion visit, * expectation of change in the current hormonal treatment during the study, * anti-allergic, antibiotic, anti-inflammatory, dermatological treatment or corticosteroid therapy within 2 weeks before the inclusion visit, * having a chronic pathology, * performing or prevision to perform another test during the study or during the exclusion period, * employee of the COSderma laboratory, * pregnant or breast-feeding woman, * woman not taking precaution to prevent pregnancy. The non-inclusion specific criteria were the following ones: * application of care products to the face within 48 hours preceding the inclusion visit, * application of make-up products to the face the day of the inclusion visit, * face wash with any other means than clear water (no soap or cleanser) on the day of the inclusion visit, * application of self-tanning products to the face within 4 weeks preceding the inclusion visit, * Oral intake of food supplement within 1 month preceding the inclusion visit, * cutaneous marks on the face which could interfere with the skin's clinical signs assessment (pigmentation issues, scar tissues, over-developed hairiness, too many ephelides and naevi, sunburns...), * solar exposition (natural sun or UVA or heliotherapy treatment) within 4 weeks preceding the inclusion visit and expectation of solar exposition (natural or UVA) during the study, * Vitamin A acid treatment or its derivatives within 3 months preceding the pre-inclusion visit, * Retinoid based oral treatment within 6 months before the pre-inclusion visit, or local treatment within 2 months prior to this visit, * Carotene based treatment within 4 weeks preceding the inclusion visit, * expectation or having undergone aesthetic or dermatological surgery on the face.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Health behavior are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Health Behavior

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • COSderma China Laboratory (Wuhan, China)

    Wuhan, Hubei, 430071, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.